Candriam Luxembourg S.C.A. »

Crinetics Pharmaceuticals In shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 288k 35.58

More positions owned by Candriam Luxembourg S.C.A.

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Procter & Gamble Company (PG)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Ikarian Capital
Lord, Abbett & Co
Dimensional Fund Advisors

View all funds holding Crinetics Pharmaceuticals In